January 23, 2025 06:16 AM ESTUpdated 06:27 AM

Teva’s MS drug and generics to add black box warning for anaphylaxis

Ayisha Sharma

News Reporter

The FDA has issued a new boxed warning for Teva Pharmaceuticals’ multiple sclerosis drug Copaxone and generic versions marketed by other companies after some patients …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Teva’s MS drug and generics to add black box warning for anaphylaxis

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’

Anthos' detailed mid-stage data back its anticoagulant, but can the drug succeed where Bayer's failed?

BioMarin turns to ex-Roche dealmaker James Sabry to build ‘next version’ of 27-year-old company

China's biotech boom is threatening US drugmakers' dominance

Chinese startup begins first trial of in vivo CRISPR therapy for blood disease

Fueling More Breakthroughs: Manufacturing Innovation to Expand Gene Therapy’s Reach

Te­va’s MS drug and gener­ics to add black box warn­ing for ana­phy­lax­is

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Teva’s MS drug and generics to add black box warning for anaphylaxis